Dow Up0.64% Nasdaq Up0.68%

Fidelity Select Medical Equip & Systems (FSMEX)

39.02 Up 0.24(0.62%) Sep 18

Profile as of Aug 30, 2014Get Profile for:
Fidelity Select Medical Equip & Systems
Fidelity Select Portfolios82 Devonshire StreetBoston MA 02109
Phone: 800-544-8544
Fund Overview 
Fund Family:Fidelity Investments
Net Assets:1.69B
Year-to-Date Return:13.22%
Morningstar Rating:2 stars
Fund Inception Date:Apr 28, 1998
Morningstar Style Box 
[View Category Definition]
View Top Health Funds
About the Morningstar Style Box
Management Information 
Edward L. Yoon
Lead Manager since May 1, 2007
Edward Yoon is a manager. Since joining Fidelity Investments in 2006, Mr. Yoon has served as a research analyst and portfolio manager. Prior to joining Fidelity, he worked for JPMorgan Asset Management as a research analyst and co-fund manager from 2002 until 2006. Mr. Yoon received a BA in business economics from Brown University in 2002.
Investment Information 
Min Initial Investment:2,500
Min Initial Investment, IRA:500
Min Initial Investment, AIP:2,500
Min Subsequent Investment:N/A
Min Subsequent Investment, IRA:N/A
Min Subsequent Investment, AIP:200
FSMEX can be purchased from 88 brokerages.

Fund Summary 
The investment seeks capital appreciation. The fund normally invests at least 80% of assets in securities of companies principally engaged in research, development, manufacture, distribution, supply, or sale of medical equipment and devices and related technologies. It invests primarily in common stocks. The fund invests in domestic and foreign issuers. It uses fundamental analysis of factors such as each issuer's financial condition and industry position, as well as market and economic conditions to select investments. The fund is non-diversified.

Fund Operations 
Last Dividend : 0.00
Last Cap Gain (Apr 10, 2014) : 0.00
Annual Holdings Turnover (Sep 16, 2014) : 75.00%
Average for Category:51.88%
Fees & Expenses 
ExpenseFSMEXCategory Avg
Annual Report Expense Ratio (net):0.79%1.39%
Prospectus Net Expense Ratio:0.80%N/A
Prospectus Gross Expense Ratio:0.80%N/A
Max 12b1 Fee:N/AN/A
Max Front End Sales Load:N/A5.28%
Max Deferred Sales Load: N/A2.37%
3 Yr Expense Projection*:255669
5 Yr Expense Projection*:4441,046
10 Yr Expense Projection*:9902,047
* Per $10,000 invested